Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Safety and Efficacy of ATX-101 in the Reduction of Submental Fat

This study has been completed.
Information provided by:
Kythera Biopharmaceuticals Identifier:
First received: February 10, 2011
Last updated: October 11, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
No publications provided by Kythera Biopharmaceuticals

Publications automatically indexed to this study by Identifier (NCT Number):